DE69633179D1 - Transferrinrezeptorgene - Google Patents

Transferrinrezeptorgene

Info

Publication number
DE69633179D1
DE69633179D1 DE69633179T DE69633179T DE69633179D1 DE 69633179 D1 DE69633179 D1 DE 69633179D1 DE 69633179 T DE69633179 T DE 69633179T DE 69633179 T DE69633179 T DE 69633179T DE 69633179 D1 DE69633179 D1 DE 69633179D1
Authority
DE
Germany
Prior art keywords
transferrin receptor
nucleic acid
receptor protein
tbp1
tbp2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69633179T
Other languages
English (en)
Other versions
DE69633179T2 (de
Inventor
Sheena M Loosmore
Robin E Harkness
Anthony B Schryvers
Pele Chong
Scott Gray-Owen
Yan-Ping Yang
Andrew D Murdin
Michel H Klein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur Ltd
Original Assignee
Aventis Pasteur Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/483,577 external-priority patent/US6015688A/en
Application filed by Aventis Pasteur Ltd filed Critical Aventis Pasteur Ltd
Publication of DE69633179D1 publication Critical patent/DE69633179D1/de
Application granted granted Critical
Publication of DE69633179T2 publication Critical patent/DE69633179T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69633179T 1995-06-07 1996-06-07 Transferrinrezeptorgene Expired - Lifetime DE69633179T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US483577 1995-06-07
US08/483,577 US6015688A (en) 1993-11-08 1995-06-07 Transferrin receptor genes
US649518 1996-05-17
US08/649,518 US6361779B1 (en) 1993-11-08 1996-05-17 Transferrin receptor genes
PCT/CA1996/000399 WO1996040929A2 (en) 1995-06-07 1996-06-07 Transferrin receptor genes

Publications (2)

Publication Number Publication Date
DE69633179D1 true DE69633179D1 (de) 2004-09-23
DE69633179T2 DE69633179T2 (de) 2005-08-18

Family

ID=27047700

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69633179T Expired - Lifetime DE69633179T2 (de) 1995-06-07 1996-06-07 Transferrinrezeptorgene

Country Status (8)

Country Link
US (2) US6361779B1 (de)
EP (1) EP0833920B1 (de)
AT (1) ATE274059T1 (de)
AU (1) AU716506B2 (de)
BR (1) BR9608482A (de)
CA (1) CA2223503C (de)
DE (1) DE69633179T2 (de)
WO (1) WO1996040929A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6335182B1 (en) * 1999-03-16 2002-01-01 Aventis Pasteur Limited Recombinant Haemophilus influenzae adhesin proteins
US7785609B1 (en) 1999-03-16 2010-08-31 Sanofi Pasteur Limited Recombinant Haemophilus influenzae adhesin proteins
JP2006500963A (ja) 2002-08-02 2006-01-12 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ワクチン組成物
JP2013521770A (ja) 2010-03-10 2013-06-13 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ワクチン組成物
US20120171120A1 (en) 2010-11-30 2012-07-05 Genentech, Inc. Low affinity blood brain barrier receptor antibodies and uses therefor
BR112015030892A2 (pt) 2013-06-10 2017-08-29 Merck Sharp & Dohme Proteína de ligação ao antígeno, anticorpo monoclonal, ácido nucleico recombinante, vetor de expressão, célula hospedeira, composição farmacêutica, uso de uma proteína de ligação ao antígeno ou anticorpo humanizado, e, método para produzir uma proteína de ligação ao antígeno
US10149900B2 (en) 2013-12-02 2018-12-11 Engineered Antigens Inc. Immunogenic compositions and vaccines derived from bacterial surface receptor proteins

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4258029A (en) 1979-04-23 1981-03-24 Connaught Laboratories Limited Synthetic adjuvants for stimulation of antigenic responses
US4596792A (en) 1981-09-04 1986-06-24 The Regents Of The University Of California Safe vaccine for hepatitis containing polymerized serum albumin
US4496538A (en) 1982-07-06 1985-01-29 Connaught Laboratories, Inc. Haemophilus influenzae b polysaccharide-diphtheria toxoid conjugate vaccine
US4599231A (en) 1984-03-09 1986-07-08 Scripps Clinic And Research Foundation Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
US4599230A (en) 1984-03-09 1986-07-08 Scripps Clinic And Research Foundation Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
US4952496A (en) 1984-03-30 1990-08-28 Associated Universities, Inc. Cloning and expression of the gene for bacteriophage T7 RNA polymerase
US4601903A (en) 1985-05-01 1986-07-22 The United States Of America As Represented By The Department Of Health And Human Services Vaccine against Neisseria meningitidis Group B serotype 2 invasive disease
DE3521994A1 (de) 1985-06-20 1987-01-02 Bayer Ag N-(2-aminoacylamido-2-desoxy-hexosyl)-amide-, -carbamate und -harnstoffe, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
US5194254A (en) 1986-05-06 1993-03-16 Connaught Laboratories Limited Enhancement of antigen immunogenicity
US5141743A (en) 1989-04-27 1992-08-25 University Technologies International, Inc. Method for isolating and purifying transferrin and lactoferrin receptor proteins and vaccines containing the same
US6159502A (en) 1991-04-02 2000-12-12 Biotech Australia Pty Ltd Oral delivery systems for microparticles
GB9224584D0 (en) 1992-11-23 1993-01-13 Connaught Lab Use of outer membrane protein d15 and its peptides as vaccine against haempohilus influenzae diseases
ES2270420T3 (es) 1993-11-08 2007-04-01 Sanofi Pasteur Limited Genes receptores de la transferrina de haemophilus.

Also Published As

Publication number Publication date
CA2223503A1 (en) 1996-12-19
JPH11506335A (ja) 1999-06-08
ATE274059T1 (de) 2004-09-15
WO1996040929A2 (en) 1996-12-19
AU716506B2 (en) 2000-02-24
CA2223503C (en) 2010-05-04
JP3516688B2 (ja) 2004-04-05
BR9608482A (pt) 2001-07-31
US7118749B2 (en) 2006-10-10
DE69633179T2 (de) 2005-08-18
AU6117796A (en) 1996-12-30
US6361779B1 (en) 2002-03-26
WO1996040929A3 (en) 1997-03-06
EP0833920A2 (de) 1998-04-08
EP0833920B1 (de) 2004-08-18
US20030088086A1 (en) 2003-05-08

Similar Documents

Publication Publication Date Title
DK0728200T3 (da) Haemophilus-transferrin-receptorgener
ATE380867T1 (de) Lactoferrinrezeptorgen von moraxella
EP0232229B1 (de) Klonierung und Expression einer Bordetella pertussis-Toxin-kodierenden DNS
DE69333802T8 (de) Äusseres membranprotein von haemophilus
ATE133681T1 (de) Mykobakterielle rekombinanten und peptide
HUP0202882A2 (en) Novel b7-4 molecules and uses therefor
NZ500540A (en) Purified proteins, fusion proteins, recombinant vector, vaccine, kit, comprising proteins from Actinobacillus pleuropneumoniae
DE3752131D1 (de) Impfstoffe und diagnosetest für haemophilus influenzae
KR960701096A (ko) 그룹 B 스트렙토코커스의 많은 균주들에 대한 면역성을 제공하는 세포 표면 단백질인 Rib 단백질, 그 단백질의 정제방법, 시약키트 및 제약조성물(PROTEIN RIB. A CELL SURFACE PROTEIN THAT CONFERS IMMUNITY TO MANY STRAINS OF THE GROUP B STREPTOCOCCUS; PROCESS FOR PURIFICATION OF THE PROTEIN, PEAGENT KIT AND PHARMACEUTICAL COMPOSITION)
DE69633179D1 (de) Transferrinrezeptorgene
NZ335633A (en) Production of recombinant H. pylori polypeptides for treatment and diagnosis of H. pylori related diseases
ATE124420T1 (de) Impfstoffe und testsätze für haemophilus influenzae.
MX9709527A (es) Genes receptores de transferrina.
EP1905831A3 (de) Lactoferrin-Rezeptorgene von Moraxella
AU1540795A (en) Diagnosis and treatment of infections due to streptococci and enterococci
DK595187A (da) Minactivin og fremgangsmaade til fremstilling deraf
WO1999052947A3 (en) TRANSFERRIN RECEPTOR GENES OF $i(MORAXELLA)
Garvey DNA SEQUENCE ANALYSIS OF BACILLUS PHAGE PHI29 RIGHT EARLY REGION AND LATE GENES 14, 15 AND 16 (LYSOZYME)
TH16377A (th) วัคซีนป้องกันโรคบิดสำหรับสัตว์ปีก

Legal Events

Date Code Title Description
8364 No opposition during term of opposition